|  | | | | | | | | Of the 37 sick, 22 people were said to have eaten Wendy's sandwiches with romaine lettuce in Michigan, Ohio, Indiana and Pennsylvania in the week before they fell ill. | | | | | | Health authorities in the Democratic Republic of Congo are investigating a suspected case of Ebola in the country's east, the World Health Organization said on Saturday. | | | | | | Indonesia has confirmed its first monkeypox infection, detected in a person who had returned from an unidentified country with documented cases, a health ministry spokesman said on Saturday. | | | | | | North Korea imported more than 1 million facial masks and 15,000 pairs of rubber gloves from China in July, shortly before declaring victory over COVID-19, Chinese trade showed on Saturday. | | | | | | The U.S. Food and Drug Administration (FDA) has asked Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment, the regulator said on Friday. | | | | | | John Hancock Life & Health Insurance Co will pay $26.3 million to settle a New York probe that found it prematurely terminated long-term care policies before policyholders, many now dead, exhausted their benefits. | | | | | | Fresenius SE said its long-serving Chief Executive Stephan Sturm would quit, to be replaced by the head of its drugs unit, after the diversified group's earnings were hit following the COVID pandemic and a surge in costs. | | | | | | Canada's health ministry on Friday said it had authorized the use of Pfizer Inc's and BioNTech's COVID-19 vaccine as a booster for children five to 11 years old at least six months after receiving their initial two doses. | | | | | | European countries could stretch out limited supplies of the monkeypox vaccine by administering smaller doses of the shot, the European Medicines Agency (EMA) said on Friday. | | | | | | Axsome Therapeutics Inc on Friday gained U.S. approval for its treatment for depression, giving more than 20 million Americans affected by the disorder a new option in a market crowded by older drugs. | | | | | | | | | | | | | | | Sponsors are not involved in the creation of these or any other Reuters news articles.
We want to know what you think of our newsletter. Please click here to take a short survey.
Get Reuters News App
To manage which newsletters you're subscribed to, click here.
Want to stop receiving this email? Unsubscribe here.
| | | | | | | | | |
